Meet Kumar
Overview
Explore the profile of Meet Kumar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehta P, Raut S, Rastogi N, Kumar M, Dua V, Bhargava R
Indian J Hematol Blood Transfus
. 2024 Jul;
40(3):508-510.
PMID: 39011254
Antibodies directed against donor-specific HLA loci (DSA) has been proved as a main culprit for graft rejection, more specifically in HLA mismatched and haplo-identical transplant settings. There is no standardized...
2.
Choudhury D, Kumar M, Sharma S, Khandelwal V, Doval D, Dadu T, et al.
Blood Cell Ther
. 2023 Jun;
3(2):32-36.
PMID: 37313366
Introduction: Stem cell transplantation is the cornerstone of therapy for transplant-eligible patients with severe aplastic anemia. Materials And Methods: Patients with severe aplastic anemia undergoing stem cell transplantation (including matched...
3.
Bansal S, Bhargava R, Singh A, Kumar M, Kurmi S, Agrawal P
J Glob Infect Dis
. 2021 Jul;
13(2):110-111.
PMID: 34194184
No abstract available.
4.
Borah P, Mirgh S, Sharma S, Bansal S, Dixit A, Dolai T, et al.
Blood Cells Mol Dis
. 2020 Dec;
87:102525.
PMID: 33338697
Background: There is scarcity of data on outcome of COVID-19 in patients with hematological malignancies. Primary objective of study was to analyse the 14-day and 28-day mortality. Secondary objectives were...
5.
Khandelwal V, Sharma S, Doval D, Kumar M, Choudhary D, Sharma R, et al.
Indian J Hematol Blood Transfus
. 2020 Jul;
36(3):588-589.
PMID: 32647443
No abstract available.
6.
Doval D, Choudhary D, Sharma S, Khandelwal V, Kumar M, Handoo A, et al.
Indian J Hematol Blood Transfus
. 2020 Jul;
36(3):565-568.
PMID: 32647434
Hematopoietic stem cell transplantation (HSCT) is the only treatment option for the hematological manifestations of Fanconi anemia (FA). Fludarabine based reduced intensity conditioning regimens have helped in improving outcomes significantly...
7.
Sharma S, Doval D, Khandelwal V, Kumar M, Choudhary D
Indian J Hematol Blood Transfus
. 2019 Nov;
35(4):711-713.
PMID: 31741624
Risk of diabetes mellitus increases after solid organ and hematopoietic stem cell transplantation. Diabetic ketoacidosis has been reported after solid organ transplantation in patients receiving tacrolimus but has rarely been...
8.
Doval D, Sharma S, Choudhary D, Kumar M, Khandelwal V
Br J Haematol
. 2019 Aug;
187(3):274.
PMID: 31385288
No abstract available.
9.
Khandelwal V, Sharma S, Doval D, Kumar M, Choudhary D
Ann Hematol
. 2019 Aug;
98(10):2425-2426.
PMID: 31375859
No abstract available.
10.
Doval D, Sharma S, Kumar M, Khandelwal V, Choudhary D
J Oncol Pharm Pract
. 2019 May;
26(2):471-473.
PMID: 31117913
Cytarabine, a pyramidine analog, is used for treating various hematological malignancies such as acute leukemias and lymphomas. Side effects of cytarabine are dose dependent and include bone marrow suppression, fever,...